The following table shows the list of Horizon 2020 projects developed by "HEALTH IQ LIMITED". Projects are ordered by starting date.
Click on table headers to rearrange data.
| # | acronym | programme | role | EC contrib. | start | views |
|---|---|---|---|---|---|---|
| 1 | DO-IT | H2020-EU.3.1.7. | participant | 0.00 | 2017-02-01 | 1213 |
| totale | 0.00 | |||||
This organization collaborated with partners in 12 countries.
Within the project DO-IT this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | UK | ABPI | THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (OTH) |
| participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
| participant | SE | IHE | IHE, INSTITUTET FOR HALSO- OCH SJUKVARDSEKONOMI AKTIEBOLAG (PRC) |
| participant | NO | NoMA | STATENS LEGEMIDDELVERK (PUB) |
| participant | CH | Celgene | CELGENE MANAGEMENT SARL (PRC) |
| participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
| participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
| participant | SE | TLV | TANDVARDS-OCH LAKEMEDELSFORMANSVERKET (PUB) |
| participant | ES | FI | ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA (OTH) |
| participant | DE | VFA | VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV (OTH) |
| participant | BE | EMSP | THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL (OTH) |
| participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
| participant | BE | ECPC | EUROPEAN CANCER PATIENT COALITION (OTH) |
| participant | DE | TMF | TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV (REC) |
| participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
| participant | BE | Amgen | AMGEN (PRC) |
| participant | UK | ELI LILLY | Eli Lilly and Company Limited (PRC) |
| participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
| participant | DE | InterSystems | INTERSYSTEMS GMBH (PRC) |
| participant | UK | Pfizer | PFIZER LIMITED (PRC) |
| participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
| participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
| participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
| participant | NO | NIPH | FOLKEHELSEINSTITUTTET (REC) |
| participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
| participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
| participant | IT | CERGAS | UNIVERSITA COMMERCIALE LUIGI BOCCONI (HES) |
| participant | HU | SU | SEMMELWEIS EGYETEM (HES) |
| coordinator | UK | LSE | LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE (HES) |
| participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
| participant | DK | Novo | NOVO NORDISK A/S (PRC) |
| participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
| participant | UK | ULIV | THE UNIVERSITY OF LIVERPOOL (HES) |
| participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
| participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |